We are Committed to being a Collaborative Platform for Innovative Biotech Companies from around the World.
Viva BioInnovator ("VBI") is the investment division of Viva Biotech Holdings (1873.HK). We are solely dedicated to the identification and success of early-stage, biotech start-ups for Viva’s incubation, equity-for-service, and investment platforms. Our commitment is to operate a collaborative platform for innovative biotech companies from around the world, and for anyone aiming to develop an idea with transformative or strong potential.
We invest in some of the most innovative founders to build a unique portfolio covering a wide range of indications and drug types.
Read the most up to date information about us and our partners.
Boston, MA 09/11/19 - At the recent RESI conference in the Boston, Viva Biotech Chief Business Officer and Head of Viva ...
To: Business Editor [For Immediate Release]Viva Biotech Holdings(Stock Code: 1873.HK)Viva Biotech Announces 2019 Inter...
San Diego, CA August 15, 2019Viva Biotech was a proud sponsor of the last Sino-American Biotechnology and Pharmaceutical
Viva was a core supporter of Qiyu Bio as they closed their Series A financing which will help to move their main assets through pre...
Members of the VBI BioInnovator (VBI) team, David Xu - CBO, Daniel Mao - Senior Associate, Sean Ye – CSO and Yi...
On Nov. 14th, 2018, Viva Biotech held its inaugural Partnering Reception in San Diego, one of the biotech hubs in the U.S,
